The 100 Most Influential CEOs in Oncology in 2025 (Full List)

100 Most Influential CEOs

"Peace is the Best Medicine" - WHO Director-General Announces What Healthcare is Missing

Tedros Adhanom Ghebreyesus, Director-General

TWINPEAK study: Spevatamig Plus Gemcitabine and Nab-Paclitaxel as 1L Therapy in CLDN18.2 Positive mPDAC

TWINPEAK study

Highlights from ASCO GI 2026 by Wafik El-Deiry

ASCO GI 2026

Adham Jurdi Has Been Appointed Sr Medical Director of GI Oncology and Innovations at Natera

Adham Jurdi

CRITICS-II Trial at ASCO GI: Total Neoadjuvant Therapy in Resectable Gastric Cancer

CRITICS-II Trial

Dual Checkpoint Blockade in Refractory Anal Squamous Cell Carcinoma

Anal Squamous Cell Carcinoma

CheckMate 9DW at ASCO GI 2026: Nivolumab plus ipilimumab vs lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma

CheckMate 9DW

Senate Finance Committee